GleamWall
中文EN

SIGA SIGA TECHNOLOGIES INC

Pharmaceutical Preparations · Nasdaq · SEC CIK 1010086 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-69.6%
TTM net income YoY-99.1%
TTM EPS YoY-99.0%
Revenue 3-yr CAGR14.6%
Net income 3-yr CAGR—

Margins

Gross margin54.0%
Operating margin-14.2%
Net margin1.3%
FCF margin-22.1%
EBITDA margin-13.0%

Returns

ROE0.4%
ROA0.3%
ROIC (approx.)-15.0%
Asset turnover0.26x

Leverage & solvency

Liabilities / assets5.4%
Debt / equity0.00x
Current ratio24.57x
Interest coverage—

Cash quality & payout

Operating cash flow / net income-16.81x
Accruals ratio6.0%
Payout ratio6,325.2%
Capex / revenue0.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$94.57M$138.72M
Cost of revenue$29.70M$31.29M
Gross profit$64.87M$107.43M
R&D expense$19.96M$12.31M
SG&A expense$21.21M$25.14M
Operating income$23.70M$69.98M
Pretax income$30.38M$76.07M
Income tax$7.10M$16.86M
Net income$23.28M$59.21M
EBITDA$24.26M$70.52M
EPS (basic)0.330.83
EPS (diluted)0.320.82
Dividends declared per share0.600.60
Weighted avg. shares (diluted)71.87M71.91M
Balance sheet
Cash & equivalents$154.97M$155.40M
Receivables$3.26M$21.17M
Inventory$49.05M$49.56M
Current assets$212.86M$231.04M
PP&E, net$1.09M$1.30M
Goodwill$898,334$898,334
Total assets$219.47M$244.34M
Current liabilities$17.99M$25.33M
Total liabilities$20.65M$28.53M
Shareholders' equity$198.82M$215.80M
Shares outstanding71.61M71.40M
Cash flow statement
Operating cash flow$43.47M$48.76M
Capital expenditure$355,009$42,450
Free cash flow$43.12M$48.72M
Investing cash flow-$355,009-$42,450
Financing cash flow-$43.55M-$43.46M
Depreciation & amortization$562,607$538,421
Stock-based compensation$3.68M$3.64M
Dividends paid$43.12M$42.67M
Share buybacks$0$0

Free plan shows the latest 2 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.